NanoViricides Inc (NNVC)

[Its_lose_not_loose]

I think everyone can agree that NNVC is in trouble when alternative methods of financing, such as blockchain/tokens or warrants, are needed to keep NNVC from sinking. When the company can't stay afloat based on investor belief in the core business model, presumably creating drugs to combat viruses, then one should question the validity of ambiguous means of securing additional financing. If an investor doesn't believe that NNVC common stock (existing shares purchased on the open market, a non-dilutive event) are worth the risk, would they then risk sinking funds into something as nebulous, unproven and faddish as tokens?

Regardless of the method of financing, whether traditional or whimsical, NNVC appears to be a huge risk given they have been unable to identify a lead candidate even after receiving the accolades from prestigious collaborators such as Dr. Moffat.

If Moffat's thumbs up from months ago can't eek out an INDA, what can? Is all hope lost at this juncture given NNVC's rapidly dwindling reserves and the amount of time and money needed to get the cides through the FDA approval process?